Search research articles
Contact Us
Filters
Showing results (461-470 of 473) with videos related to
Page
of 48
Sort By:
Actas Dermo-Sifiliograficas
|
September 11, 2013
Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology
L Puig, J M Carrascosa, G Carretero, et al.
Plos One
|
February 13, 2016
Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome
Maribel Forero-Castro, Cristina Robledo, Rocío Benito, et al.
Leukemia Research
|
April 11, 2022
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria
A Triguero, B Xicoy, L Zamora, et al.
Journal of Hematology & Oncology
|
July 26, 2018
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
E Genescà, A Lazarenkov, M Morgades, et al.
Leukemia
|
December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
M Brüggemann, A Schrauder, T Raff, et al.
British Journal of Haematology
|
March 28, 2019
The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients
Jordi Ribera, Isabel Granada, Mireia Morgades, et al.
British Journal of Cancer
|
May 31, 2017
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
Maribel Forero-Castro, Cristina Robledo, Rocío Benito, et al.
Neurology
|
September 28, 2007
Patterns of Guillain-Barre syndrome in children: results from a Mexican population
I Nachamkin, P Arzarte Barbosa, P Arzate Barbosa, et al.
Annals of Hematology
|
May 16, 2015
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies
Miguel A Sanz, Pau Montesinos, Haesook T Kim, et al.
ESMO Open
|
March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larrán, et al.
Page
of 48
Search research articles
Search
Showing results (461-470 of 473) with videos related to
Sort By:
Page
of 48
Actas Dermo-Sifiliograficas
|
September 11, 2013
Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology
L Puig, J M Carrascosa, G Carretero, et al.
Plos One
|
February 13, 2016
Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome
Maribel Forero-Castro, Cristina Robledo, Rocío Benito, et al.
Leukemia Research
|
April 11, 2022
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria
A Triguero, B Xicoy, L Zamora, et al.
Journal of Hematology & Oncology
|
July 26, 2018
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
E Genescà, A Lazarenkov, M Morgades, et al.
Leukemia
|
December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
M Brüggemann, A Schrauder, T Raff, et al.
British Journal of Haematology
|
March 28, 2019
The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients
Jordi Ribera, Isabel Granada, Mireia Morgades, et al.
British Journal of Cancer
|
May 31, 2017
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
Maribel Forero-Castro, Cristina Robledo, Rocío Benito, et al.
Neurology
|
September 28, 2007
Patterns of Guillain-Barre syndrome in children: results from a Mexican population
I Nachamkin, P Arzarte Barbosa, P Arzate Barbosa, et al.
Annals of Hematology
|
May 16, 2015
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies
Miguel A Sanz, Pau Montesinos, Haesook T Kim, et al.
ESMO Open
|
March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larrán, et al.
Page
of 48